Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Experts: GOP Rift Could Derail Califf Nomination, Time Is Key

Executive Summary

While former FDA commissioner Califf was likely picked to head the agency again because he’s already been vetted, some Republicans may use his nomination as a political opportunity to deny Biden a win.

You may also be interested in...



Robert Califf Nominated To Retake FDA Commissioner Role

President Biden’s pick for FDA commissioner should remember many of the hot-button issues that he would face if confirmed to a second stint as the nation's top medtech regulator.

FDA’s Woodcock Pitches Large IT Modernization Plan

In a new blogpost the US FDA acting commissioner says millions of extra dollars in President Joe Biden’s recently proposed budget would help integrate the agency’s IT systems and improve efficiencies.

US FDA-Sponsored Cybersecurity Threat Modeling Playbook Tries To Make It Simple

The MITRE corporation and MDIC have produced a manual on how to use cybersecurity threat modeling to make safer medical devices. The document asks four basic questions and provides helpful examples.

Topics

UsernamePublicRestriction

Register

MT144721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel